Bausch Health Companies | Capitale Di Prestito



Loan Capital Cambiamento Data
Amgen USD 56.55B 305M 2024-12
ANI Pharmaceuticals USD 614.92M 302M 2024-12
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 21.05B 154M 2024-09
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Danaher USD 15.5B 824M 2024-12
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
Novo Nordisk 51.45B 156M 2024-09
Pacira USD 383.54M 2.35M 2024-12
Perrigo USD 3.58B 730.9M 2024-12
Prestige Brands USD 996.05M 55.67M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zoetis USD 5.22B 1.35B 2024-12



Bausch Health Companies Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.